@jayc:
$Novavax(NVAX)$I reviewed all GMP and cGMP certificates for the Novavax's global sites. I can fully understand why Novavax leveraged the manufacturing partnership with Serum. This strategy really makes their CMC package harmonized and simplified as Serum's MHRA GMP certificate covers full line-up of the manufacturing operations from DS/DP to QC Testing without requiring any combinations of sites.Serum's MHRA GMP Coverage1. Manufacturing Operations2. 1.1 Sterile Products3. 1.3 Biological medical products4. 1.4 Other products or manufacturing activity5. 1.5 Packaging6. 1.5.1 Primary packaging7. 1.5.2 Secondary packaging8. 1.6 Quality control testing If Novavax uses other global sites, they need to combine several sites to manufacture Nuvaxovid from DS